Literature DB >> 1845921

Cat-scratch disease. Acute encephalopathy and other neurologic manifestations.

H A Carithers1, A M Margileth.   

Abstract

Seventy-six patients with neurologic complications of cat-scratch disease are discussed. Encephalopathy occurred in 61, while 15 had either cranial or peripheral nerve involvement. The average age of the patients with encephalopathy was 10.6 years (range, 1 to 66 years), and almost twice as many males as females were affected in contrast to patients with uncomplicated cat-scratch disease, in which the ratio was almost equal. Fever was not documented in 50% of patients with encephalopathy and only 26% had temperatures higher than 39 degrees C. Convulsions occurred in 46% and combative behavior in 40%. Lethargy with or without coma was accompanied by variable neurologic signs. Results of laboratory studies, including imaging of the central nervous system, were inconsistent and nondiagnostic. Biopsy tissue from 14 patients showed histopathologic findings compatible with cat-scratch disease. The "English-Wear bacillus" was demonstrated by the Warthin-Starry stain in 10 of 14 skin or lymph node specimens. Of the 15 patients without encephalopathy, two children with facial nerve paresis displayed cranial nerve symptoms and/or signs, 10 patients had cat-scratch disease neuroretinitis, and three women had peripheral neuritis. All 76 patients recovered within 12 months; 78% recovered within 1 to 12 weeks. There were no neurologic sequelae. Treatment consisted of control of convulsions and supportive measures. Commonly used antibiotics administered to more than half of the patients were apparently ineffective.

Entities:  

Mesh:

Year:  1991        PMID: 1845921     DOI: 10.1001/archpedi.1991.02160010104026

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  21 in total

1.  Differentiation of pathogenic Bartonella species by infrequent restriction site PCR.

Authors:  S A Handley; R L Regnery
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

Review 2.  Bartonella spp. as emerging human pathogens.

Authors:  B E Anderson; M A Neuman
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

3.  Encephalopathy in an adult with cat-scratch disease.

Authors:  Michael Samarkos; Vasiliki Antoniadou; Aristeidis G Vaiopoulos; Mina Psichogiou
Journal:  BMJ Case Rep       Date:  2018-03-05

4.  Infection of fetal feline brain cells in culture with Bartonella henselae.

Authors:  K R Muñana; S M Vitek; B C Hegarty; D L Kordick; E B Breitschwerdt
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

Review 5.  Intruders below the radar: molecular pathogenesis of Bartonella spp.

Authors:  Alexander Harms; Christoph Dehio
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

6.  Study of genotypes and virB4 secretion gene of Bartonella henselae strains from patients with clinically defined cat scratch disease.

Authors:  Sophie Woestyn; Nathalie Olivé; Geoffroy Bigaignon; Véronique Avesani; Michel Delmée
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

7.  Comparison of in-house and commercial slides for detection by immunofluorescence of immunoglobulins G and M against Bartonella henselae and Bartonella quintana.

Authors:  M Maurin; J M Rolain; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

8.  Expressive aphasia as a presentation of encephalitis with Bartonella henselae infection in an immunocompetent adult.

Authors:  Carla B Marienfeld; Daniel B Dicapua; Gordon K Sze; Jonathan M Goldstein
Journal:  Yale J Biol Med       Date:  2010-06

9.  Seroprevalence of Bartonella henselae in patients with uveitis and healthy individuals in Tokyo.

Authors:  Koju Kamoi; Tomoko Yoshida; Hiroshi Takase; Mako Yokota; Tatsushi Kawaguchi; Manabu Mochizuki
Journal:  Jpn J Ophthalmol       Date:  2009-10-22       Impact factor: 2.447

10.  Disseminated cat-scratch disease: detection of Rochalimaea henselae in affected tissue.

Authors:  K Waldvogel; R L Regnery; B E Anderson; R Caduff; J Caduff; D Nadal
Journal:  Eur J Pediatr       Date:  1994-01       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.